Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Bovine Liver Organoids for Dairy Cow Fatty Liver
2026-09-04
Lei et al. developed a bovine liver organoid system that reproduces key features of fatty liver induced by oleic and palmitic acids, including triglyceride and cholesterol accumulation. The model also supported comparative testing of natural compounds and atorvastatin, providing a species-relevant platform for mechanism studies and early therapeutic screening with reduced reliance on live animals.
-
BKT140 CXCR4 Antagonist: Oncology Workflows
2026-09-03
Build reproducible CXCR4 inhibition studies with BKT140 (BL-8040), from CXCL12-driven migration assays to apoptosis and hematopoietic stem cell mobilization. This practical guide connects assay design, formulation, orthogonal readouts, and troubleshooting for tumor microenvironment research.
-
gamma-Glu-Cys (γ-Glu-Cys) Assay Guide
2026-09-03
Learn how gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, can improve substrate control in glutathione synthetase enzyme assays and redox-sensitive cell workflows. This scenario-based guide covers stock preparation, assay compatibility, interpretation, vendor selection, and evidence-based handling limits.
-
ETS1–SENP2 Axis in BPD Mitophagy
2026-09-02
A 2026 study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-induced bronchopulmonary dysplasia. The work links ETS1 to SENP2-dependent FUNDC1 deSUMOylation, HSPA8 binding, and FUNDC1 degradation, defining a mechanism by which excessive mitochondrial damage-induced autophagy may be restrained during lung injury.
-
Arachidonic Acid Research Workflows
2026-09-02
Build more controlled inflammation, eicosanoid, and immune-signaling assays with a practical workflow for Arachidonic Acid. The guide connects pathway-focused lipid experiments with emerging evidence that dietary arachidonate can accelerate vaccine-associated humoral immunity, while emphasizing formulation, controls, and interpretation limits.
-
Angiotensin III: RAAS Mechanism and Research Use
2026-09-01
Angiotensin III is the endogenous RAAS peptide Arg-Val-Tyr-Ile-His-Pro-Phe, with pressor, aldosterone-regulating, and receptor-signaling activity. Product specifications and peer-reviewed evidence support its use as a cardiovascular research peptide, while assay-specific limitations prevent direct clinical or antiviral conclusions.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-09-01
A 2019 Journal of Medicinal Chemistry study used anthraquinone-based optimization and allosteric-site modeling to identify compound 8c as a potent pyruvate dehydrogenase kinase 4 inhibitor. The compound showed promising biochemical, pharmacokinetic, metabolic, glucose-tolerance, allergy, and cancer-related activity in preclinical models, while also illustrating the limitations of translating multi-assay findings into an oral therapy.
-
JIB-04 Targets Colorectal Cancer Stem Cells
2026-08-31
The reference study identified JIB-04 as a small-molecule histone demethylase inhibitor that preferentially suppresses colorectal cancer stem cell phenotypes. Its integrated sphere, migration, transcriptomic, reporter, and in vivo analyses connect epigenetic inhibition with reduced Wnt/β-catenin activity, while also defining important limits for mechanistic and therapeutic interpretation.
-
AMG 9810: TRPV1 Antagonist Research Guide
2026-08-31
AMG 9810 is a competitive TRPV1 antagonist with nanomolar activity at human and rat TRPV1 receptors. It supports controlled studies of capsaicin-evoked calcium influx, CGRP release, sensory neuron signaling, and pain mechanisms.
-
40-Hz Flicker and Retinal Amyloid Clearance
2026-08-30
A 2026 mouse study links 40-Hz light flicker to increased MHC-II expression, microglial activation, and amyloid-β clearance in the aging retina. Its minocycline-based inhibition experiment supports microglial activity as a necessary component of the response, while also highlighting important limits for translating induced amyloid models to human age-related macular degeneration.
-
Naloxone hydrochloride: Research Workflows
2026-08-29
Build cleaner opioid receptor signaling experiments with a high-purity antagonist suited to receptor, neural stem cell, immune, and behavioral models. This guide translates naloxone hydrochloride into practical assay workflows while using a PDK4 inhibitor study as a framework for staged validation—not as evidence of a shared mechanism.
-
Ciprofloxacin: 5 Reliable Assay Scenarios
2026-08-28
This scenario-driven guide explains how Ciprofloxacin, SKU A8399, can support antimicrobial resistance research while preventing misinterpretation of cell viability, proliferation, and cytotoxicity readouts. It covers mechanism, compatibility, controls, resistance-aware interpretation, and practical product-selection criteria using product specifications and recent epidemiological evidence.
-
Acetylcysteine in 3D Tumor-Stroma Assays
2026-08-28
Learn how Acetylcysteine and N-acetyl-L-cysteine can be deployed as controlled redox perturbations in organoid–fibroblast models, rather than treated as generic antioxidants. This workflow connects oxidative stress pathway modulation with patient-specific chemoresistance assays and provides practical dosing, controls, and troubleshooting guidance.
-
Staurosporine: Kinase Signaling Workflow Guide
2026-08-27
Build reproducible apoptosis and kinase-signaling assays with Staurosporine, while separating genuine pathway effects from cryopreservation and handling artifacts. This guide combines dose–time design, THP-1 assay preparation, VEGFR signaling applications, and practical troubleshooting for cancer research.
-
Imipenem for Spatial Antimicrobial Research
2026-08-27
Imipenem can serve as more than a broad-spectrum antibacterial research reagent. This article examines how its PBP-directed activity and reported immune effects could be evaluated within spatially resolved implant and sepsis assays, while clearly separating established evidence from future platform applications.